In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cyclenium Pharma Inc.

www.cyclenium.com

Latest From Cyclenium Pharma Inc.

Bursting Bacteria And Busting Resistance: AiCuris And Lysando’s New Partnership

German anti-infectives firm AiCuris partners to develop new class of Artilysin antimicrobials that rapidly burst bacterial cells and could have an improved resistance profile.

Deals Infectious Diseases

Bridging The Gap: Cyclenium Pharma

Emerging Company Profile: Cyclenium Pharma spoke with Scrip about macrocyclic drug discovery, which covers the molecular space between traditional small molecules and large bio-molecules, to capture the pharmacological properties of larger peptides/proteins in metabolically stable small molecules and proven in a broad range of target classes.

Infectious Diseases StartUps and SMEs

Deal Watch: Vertex Selects First Candidate Under CRISPR Gene-Editing Collaboration

Vertex hopes to develop CTX001 as a treatment for sickle cell disease and beta thalassemia. Allergan adds stalled uterine fibroid candidate in buyout of troubled Repros, Juno licenses multiple myeloma candidate from Lilly.

Deals M & A
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Cyclenium Pharma Inc.
  • Senior Management
  • Helmut Thomas, PhD, Pres. & CEO
    Mark L Peterson, PhD, COO
  • Contact Info
  • Cyclenium Pharma Inc.
    Phone: (819) 571-4296
    7171 Frederick Banting
    Montreal, H4S 1Z9
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register